StepStone Group LP 13F holdings, Q4 2024
Holdings as of December 31, 2024 · filings on SEC EDGAR · latest filing →
StepStone Group LP disclosed 14 US equity positions worth $114.4m in its Q4 2024 13F filing. The largest position was MONEYLION, INC. at 46.8% of the reported book, followed by PATH and TRDA. Against the Q3 2024 filing, it opened 4 new positions, added to 0 and reduced 0 among the top 14 holdings.
What did StepStone Group LP own in Q4 2024? Top 14 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2024 |
|---|---|---|---|---|---|---|---|
| 1 | MONEYLION, INC. | 46.8% | $53.6m | 622,931 | 0% | held | |
| 2 | PATH UIPATH, INC. | Technology | 14.3% | $16.4m | 1,286,527 | 0% | held |
| 3 | TRDA ENTRADA THERAPEUTICS, INC. | 11.5% | $13.2m | 761,277 | 0% | held | |
| 4 | DKNG DRAFTKINGS INC | Consumer Cyclical | 10.5% | $12.0m | 321,804 | 0% | held |
| 5 | OKUR ONKURE THERAPEUTICS INC | 3.7% | $4.2m | 491,938 | – | new | |
| 6 | NEUEHEALTH INC. | 3.4% | $3.9m | 525,247 | -0% | held | |
| 7 | PHAT PHATHOM PHARMACEUTICALS, INC. | 3.0% | $3.4m | 422,085 | 0% | held | |
| 8 | COIN COINBASE GLOBAL INC | Financial Services | 2.9% | $3.3m | 13,281 | – | new |
| 9 | HILLEVAX, INC. | 1.5% | $1.7m | 826,569 | 0% | held | |
| 10 | SENTINELONE INC | 0.7% | $784.2k | 35,326 | – | new | |
| 11 | VACASA, INC. | 0.6% | $721.6k | 147,261 | 0% | held | |
| 12 | TNYA TENAYA THERAPEUTICS, INC. | 0.6% | $660.9k | 462,163 | 0% | held | |
| 13 | GROV GROVE COLLABORATIVE HOLDINGS, INC. | 0.5% | $528.7k | 380,383 | 0% | held | |
| 14 | METC RAMACO RES INC | Basic Materials | 0.0% | $38.9k | 3,787 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.